SC 13G 1 prosensa_13g.htm SCHEDULE 13G
 

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. __) *

 

Prosensa Holding N.V.

 

(Name of Issuer)

 

Common Shares

 

(Title of Class of Securities)

 

N71546100

 

(CUSIP Number)

 

November 3, 2014

 

(Date of the Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed :

 

oRule 13d-1(b)
 oRule 13d-1(c)
 xRule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provision of the Act (however, see the Notes.)

 
 

CUSIP No. N71546100

   
1. Name of Reporting Persons
   
    Gimv NV
   
2. Check the Appropriate Box if a Member of a Group
(a)  o
(b)  o
   
3. SEC Use Only
   
   
4. Citizenship or Place of Organization
   
    Belgium  

 

Number of 5. Sole Voting Power
Shares 499,382 (See Item 4)
Beneficially Owned  
by Each 6. Shared Voting Power
Reporting Person 0
   
  7. Sole Dispositive Power
  499,382 (See Item 4)
   
  8. Shared Dispositive Power
  0
   
9. Aggregate Amount Beneficially Owned by Each Reporting Person
 
  499,382 (See Item 4)
 
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
 
11. Percent of Class Represented by Amount in Row (9)
 
  1.43%
 
12. Type of Reporting Person (See Instructions)
  CO
2
 

CUSIP No. N71546100

   
1. Name of Reporting Persons
   
    Adviesbeheer Gimv Life Sciences 2007 NV
   
2. Check the Appropriate Box if a Member of a Group
(a)  o
(b)  o
   
3. SEC Use Only
   
   
4. Citizenship or Place of Organization
   
    Belgium  

 

Number of 5. Sole Voting Power
Shares 55,487 (See Item 4)
Beneficially Owned  
by Each 6. Shared Voting Power
Reporting Person 0
   
  7. Sole Dispositive Power
  55,487 (See Item 4)
   
  8. Shared Dispositive Power
  0
   
9. Aggregate Amount Beneficially Owned by Each Reporting Person
 
  55,487 (See Item 4)
 
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
 
11. Percent of Class Represented by Amount in Row (9)
 
  0.16%
 
12. Type of Reporting Person (See Instructions)
  CO
3
 
Item 1(a)Name of Issuer

 

Prosensa Holding N.V.

 

Item 1(b)Address of Issuer’s Principal Executive Offices

 

J.H. Oortweg 21, 2333 CH Leiden, The Netherlands.

 

Item 2(a)Name of Persons Filing

 

Gimv NV

Adviesbeheer Gimv Life Sciences 2007 NV

 

Item 2(b)Address of Principal Business Office or, if none, Residence

 

The address of Gimv NV and Adviesbeheer Gimv Life Sciences 2007 NV is as follows:

 

Karel Oomsstraat 37, B-2018 Antwerpen, Belgium

 

Item 2(c)Citizenship

 

Gimv NV and Adviesbeheer Gimv Life Sciences 2007 NV are both Belgium corporations.

 

Item 2(d)Title of Class of Securities

 

Common Shares

 

Item 2(e)CUSIP Number

 

N71546100

 

Item 3If this statement in filed pursuant to §§240.13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

Not applicable

 

Item 4Ownership

 

The number of shares beneficially owned by Gimv NV and Adviesbeheer Gimv Life Sciences 2007 NV is as follows:

 

Reporting Person  Amount Beneficially Owned   Percent of Class 
Gimv NV   499,382    1.43%
Adviesbeheer Gimv Life Sciences 2007 NV   55,487    0.16%

 

Reporting Person  Voting Power    Dispositive Power 
   Sole   Shared   Sole   Shared 
Gimv NV   499,382    0    499,382    0 
Adviesbeheer Gimv Life Sciences 2007 NV   55,487    0    55,487    0 
4
 

As of November 11, 2014, (i) Gimv NV is (A) the record owner of 499,382 Shares and (B) the beneficial owner of 554,869 Shares (including 55,487 Shares held of record by Adviesbeheer Gimv Life Sciences 2007 NV) and (ii) Adviesbeheer Gimv Life Sciences 2007 NV is (A) the record owner of 55,487 Shares and (B) the beneficial owner of 55,487 Shares.

 

Item 5Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

x

 

Item 6Ownership of More than Five Percent on Behalf of Another Person

 

Not applicable.

 

Item 7Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

 

Not applicable.

 

Item 8Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9Notice of Dissolution of Group

 

Not applicable.

 

Item 10Certifications

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

5
 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of November 14, 2014.

     
  GIMV NV
     
By: /s/ Alex Brabers  
    Name: Alex Brabers
    Title:   Gimv Partner
   
  By:  /s/ Edmond Bastijns  
    Name: Edmond Bastijns
    Title:   Gimv Partner
     
  Adviesbeheer Gimv Life Sciences 2007 NV
     
  By: /s/ Alex Brabers  
    Name: Alex Brabers
    Title:   Gimv Partner
     
  By: /s/ Edmond Bastijns  
    Name: Edmond Bastijns
    Title:   Gimv Partner
6
 

Exhibit Index

 

Exhibit A Joint Filing Agreement, dated November 14, 2014, between Gimv NV and Adviesbeheer Gimv Life Sciences 2007 NV.
7